Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy.
Gibson
C M
CM
Cardiovascular Division, Department of Medicine, the University of California San Francisco, San Francisco, California 94118, USA. mgibson@perfuse.org
Cohen
D J
DJ
Cohen
E A
EA
Lui
H K
HK
Murphy
S A
SA
Marble
S J
SJ
Kitt
M
M
Lorenz
T
T
Tcheng
J E
JE
D000328:Adult; D000368:Aged; D015901:Angiography, Digital Subtraction; D015906:Angioplasty, Balloon, Coronary; D017023:Coronary Angiography; D003326:Coronary Circulation / Q000187:drug effects*; D003327:Coronary Disease / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D000077542:Eptifibatide; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage* / Q000009:adverse effects; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D015607:Stents
D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D000077542:Eptifibatide